Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1999-02-03 to 1999-02-17
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted in compliance with EEC-Guideline B3 and OECD Guidelines for testing chemicals 402 according to the good laboratory practice regulations annex of paragraph 19a, section 1 of the chemical law of July, 25, 1994.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
Name of test material (as cited in study report): Reaktiv-Orange DYPR934

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:

TEST SYSTEM
Species Sprague Dawley rat
Strain HSD: Sprague Dawley SD
Origin HARLAN WINKELMANN
(SPF breeding colony)
Body weight at start of the experiment
Male animals Mean = 269 g (= 100 %)
S = ± 15.8 g
Min= 241 g (-10.4 %)
Max = 280 g (+4.1 %)
n = 5
Female animals Mean = 208 g (= 100 %)
S = ± 5.5 g
Min = 201 g (-3.4 %)
Max = 213 g (+2.4 %)
n = 5
Age at the start of the study: 6-10 weeks
Randomization Randomization schemes: 98.0941, 98.0704
Animal maintenance: in fully air-conditioned rooms in macrolon cages (type 3) on soft wood granulate one animal per cage.
Room temperature: 22 ± 3 °C
Relative humidity: 50 ± 20 %
Lighting time: 12 hours daily
Acclimatization: at least seven days
Food: ssniff® R/M-H(V 1534), ad libitum
Water: tap water in plastic bottles, ad libitum
Animal identification: cage numbering


Administration / exposure

Type of coverage:
occlusive
Vehicle:
other: Deionized water
Details on dermal exposure:
Before the dermal treatment the fur was mechanically removed from the dorsal skin of the animals over an area of approximately 30 cm2.
The appropriate amount of the test substance was moistened (0. 5 g of Reaktiv-Orange DYPR 934 with 0.5 mL of deionized water.)On two-ply gauze and aluminium foil (6X8 cm) and distributed as uniformly as possible. Together with the foil the test substance was administrated to the shaved and intact dorsal skin. The foil was held in place with an elastic plaster bandage fixed around the animal's body.
At the end of the dermal exposure period of 24 hours the bandage was removed and the treated skin area washed with warm water in order to remove any unabsorbed remnants of the substance.

Duration of exposure:
24 h
Doses:
2000 mg/kg bw.
No. of animals per sex per dose:
5 male and 5 female rats
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Symptoms were recorded twice every day (in the morning and in the afternoon), on weekends and public holidays only once. During the time the animals were weighed weekly.
- Necropsy of survivors performed: yes
- Other examinations performed:
Body weight development and clinical signs:
With exception of one female, all animals exhibited body weight gain throughout the study. No symptoms were observed after administration of 2000 mg/kg body weight.
The skin of the animals showed orange discolorations.
Autopsy findings:
The animals killed at the end of the observation period showed no macroscopically visible changes

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
Male: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Female: 2000 mg/kg bw; Number of animals: 5; Number of deaths: 0
Clinical signs:
other: No substance related toxical effects.
Gross pathology:
The animals killed at the end of the observation period showed no macroscopically visible changes/ (lesions).
Other findings:

Orange discolored skin

Any other information on results incl. tables

             Table I:             RESULTS AND COMMENTS

Lethality

No deaths occurred during the whole study

Body weight development

With exception of one female, all animals exhibited body weight gain throughout the study. No symptoms were observed after administration of 2000 mg/kg body weight.

Clinical signs

No symptoms were observed after administration of 2000 mg/kg body weight.

-The skin of the animals showed orange discolorations.

Autopsy findings

The animals killed at the end of the observation period showed no macroscopically visible changes/ (lesions).

Remarks: for individual data on clinical signs, bodyweight development and individual autopsy see tables under the rich text field: “Any other information on results incl. tables”

Dose Range finding study

Test substance: Reaktiv-Orange DYPR 934

Vehicle: dionized water

Preparation of test compound:

To check the suitability of the vehicle 0.5 g of Reaktiv-Orange DYPR 934 was moistened with 0.5 mL deionized water. For individual dosing, both test item and vehicle were mixed in proportion stated above.

                                                      Table II: Bodyweights-Individual Bodyweights

Study: 99. 0013-Acute Dermal Toxicity with Reaktiv-Orange DYPR 934 in Rats

 

Bodyweights: Individual Bodyweights

 

                                                       Day numbers relative to Start Date

 

Group

Sex

Animal Number

1

8

15

 

1m

1

273

298

313

 

 

2

280

296

311

 

 

3

241

245*

263*

 

 

4

277

288

292

 

 

5

272

293

316

 

 

Mean

268.6

284.0

299.0

 

 

S.D.

15.8

22.1

22.2

 

 

N

5

5

5

 

1 f

6

212

221

220

 

 

7

204

214

222

 

 

8

213

219

224

 

 

9

212

221

233

 

 

10

201

207

216

 

 

Mean

208.4

216.4

223.0

 

 

S.D.

5.5

6.0

6.3

 

 

N

5

5

5

 

*= result to left has an associated comment or marker

Nominal Dose: Group 1-2000 mg/kg bodyweight

 

Comments and Markers

 

Measurement

Group

Sex

Animal number

Day Number

Type

Marker Comment

Bodyweights

1 m

3

8

Out of range

 

15

Out of range

Marker= implies value excluded from means

                                                       Day numbers relative to Start Date

                                   Table III: Bodyweights Gains- Individual Bodyweight Gains

 

Group

Sex

Animal Number

From

 

To

1

 

8

8

 

15

 

1m

1

 

25

15

 

 

2

 

16

15

 

 

3

 

4*

18*

 

 

4

 

11

4

 

 

5

 

21

23

 

 

 

Mean

15.4

15.0

 

 

 

S.D.

8.9

7.0

 

 

 

N

5

5

                                   *= result to left has an associated comment or marker

                                         Nominal Dose: Group 1-2000 mg/kg bodyweight

 

Group

Sex

Animal Number

From

 

To

1

 

8

8

 

15

 

1f

6

 

9

-1

 

 

7

 

10

8

 

 

8

 

6

5

 

 

9

 

9

12

 

 

10

 

6

9

 

 

 

Mean

8.0

6.6

 

 

 

S.D.

1.9

4.9

 

 

 

N

5

5

 

 Table IV: Individual bodyweight gains

Measurement

Group

Sex

Animal number

Day Number

Type

Marker Comment

Bodyweights

1 m

3

8

Out of range

 

15

Out of range

 

 

  Table V:                        Clinical observations-Clinical Signs by Animal

                                          Day number relative to start

Group Sex

Animal Number

Clinical Sign

I

0-10 min

Post dos

I

10-30 min

Post dos

I

30-60 min

Post dos

 

1-2 hrs

Post dos

I

2-4 hrs

Post dos

I

4-8 hrs

Pos dos

1 m

1

No abnormalities Detected

X

X

X

X

X

X

 

2

No abnormalities Detected

X

X

X

X

X

X

 

3

No abnormalities Detected

X

X

X

X

X

X

 

4

No abnormalities Detected

X

X

X

X

X

X

 

5

No abnormalities Detected

X

X

X

X

X

X

 

6

No abnormalities Detected

X

X

X

X

X

X

 

7

No abnormalities Detected

X

X

X

X

X

X

 

8

No abnormalities Detected

X

X

X

X

X

X

 

9

No abnormalities Detected

X

X

X

X

X

X

 

10

No abnormalities Detected

X

X

X

X

X

X

 *= result to left has an associated comment or marker

 X=Present

 

        Table VI:                  Clinical observations-Clinical Signs by Animal

                                         Day number relative to start

 

Group Sex

Animal Number

Clinical Sign

2

3

4

5

6

7

8

9

10

11

12

13

14

15

 

1 m

1

 

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

2

 

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

3

 

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

4

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

5

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

6

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

7

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

8

Skin discolored-large area

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

 

 

9

No Abnormalities Detected

-

-

-

-

-

-

X

X

X

X

X

X

X

X

X

 

Skin discolored –large area

o

o

o

o

o

o

-

-

-

-

-

-

-

-

-

 

10

 

Skin discolored –large area

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

 X= present o= orange

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Based on the results obtained in the study the median lethal value (LD50) of Reaktiv-Orange DYPR 934 for the male and female rat is greater than 2000 mg/kg body weight.
Executive summary:

In a 24 h acute toxicity dermal study (conducted in accordance with the OECD Guideline as well as the EEC Guideline), the acute dermal toxicity of Reaktiv-Orange DYPR 934 was tested only at a dose level of 2000 mg/kg body weight of 5 male and 5 female of Sprague Dawley rats.

The observation period following treatment lasted for 14 days. Symptoms were recorded twice every day (in the morning and in the afternoon) on weekends and public holidays, only once. During this time the animals were weighed weekly. At the end of the observation period the animals were killed by carbone dioxide asphyxiation, dissected and examined for macroscopically visible changes.

The acute dermal toxicity testing of Reaktiv-Orange DYPR 934 in the rat yielded a median lethal dose (LD50) above 2000 mg/kg body weight in both male of female animals. After administration of 2000 mg/kg body weight neither death nor symptoms occurred. The skins of eight animals show orange discolorations up to day seven of the study. With exception of one female, all animals exhibited body weight gain throughout the study. The animals killed at the end of the observation period showed no macroscopically visible changes. The dermal LD50 value was considered in conjunction with the observed toxic effects and the necropsy findings. Based on the results obtained in the study the median lethal value (LD50) of Reaktiv-Orange DYPR 934 for the male and female rat is greater than 2000 mg/kg body weight.

Results Synopsis and test report:

Species

Strain

Origin

Sex of animals dosed

Tabulation of response data by dose level

LD50 Value

Findings

Sprague Dawley rats

 

HSD: Sprague Dawley SD

Harlan Winkelmann

Gartenstr. 27, 33178 Borchen

(SPF breeding colony)

Male and female

No animals died during the test.

>2000 mg/kg body weight

The animals killed at the end of the observation period showed no macroscopically visible changes.